Evidence map›Paper›PMID 37327971›Full record

ArticleNeuropharmacology2023

Strain and sex-related behavioral variability of oxycodone dependence in rats.

Michelle R Doyle, Angelica R Martinez, Ran Qiao, Selen Dirik, Francesca Di Ottavio, Glenn Pascasio, Rémi Martin-Fardon, Christopher Benner, Olivier George, Francesca Telese and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Neuropharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Michelle R DoyleDepartment of Psychiatry, University of California San Diego, School of Medicine, La Jolla, CA, USA; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Angelica R MartinezDepartment of Psychiatry, University of California San Diego, School of Medicine, La Jolla, CA, USA.
Ran QiaoDepartment of Psychiatry, University of California San Diego, School of Medicine, La Jolla, CA, USA.
Selen DirikDepartment of Psychiatry, University of California San Diego, School of Medicine, La Jolla, CA, USA.
Francesca Di OttavioDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Glenn PascasioDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Rémi Martin-FardonDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Christopher BennerDepartment of Medicine, University of California San Diego, School of Medicine, La Jolla, CA, USA.
Olivier GeorgeDepartment of Psychiatry, University of California San Diego, School of Medicine, La Jolla, CA, USA.
Francesca TeleseDepartment of Psychiatry, University of California San Diego, School of Medicine, La Jolla, CA, USA.
Giordano de GuglielmoDepartment of Psychiatry, University of California San Diego, School of Medicine, La Jolla, CA, USA. Electronic address: gdeguglielmo@health.ucsd.edu.
University of California San Diego · USScripps Research Institute · US

Funding

Viral Vector CoreP60AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI AMANDA J ROBERTS · 2003 to 2026
$46.3M
Neurpsychopharmacology-Multidisciplinary TrainingT32AA007456 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARISA ROBERTO · 1985 to 2026
$13.4M
Use of Next-Gen Sequencing to Identify Genetic Variants that Influence compulsiveOxycodone Intake in Outbred RatsU01DA044451 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Olivier George, Abraham A Palmer · 2018 to 2026
$7.3M
SYSTEMIC NEUROPHARMACOLOGYP50AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE · PI RIVIER, CATHERINE L · 1985 to 2002
$5.1M
Decoding the grammar of transcriptional enhancers regulating different stages of opioid use disorderU01DA051972 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENNER, CHRISTOPHER W, TELESE, FRANCESCA · 2020 to 2024
$3.4M
Multiomic profiling of cell types mediating opioid use disorder in ratsR01DA056602 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Giordano De Guglielmo, Francesca Telese · 2022 to 2026
$3.0M
Drug targeting the dynamics of opioid systems in alcohol dependenceR01AA028549 · NIAAA · KAROLINSKA INSTITUTE · PI MARTIN-FARDON, REMI, TALISMAN, TIJANA · 2020 to 2024
$2.6M
Pivotal role of thalamic hypocretin transmission during EtOH seeking and relapseR01AA026999 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARTIN-FARDON, REMI · 2018 to 2022
$2.2M
Cocaine-motivated behaviors: development of novel viral-based strategies to target orexinergic input to the infralimbic cortex.R21DA053443 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARTIN-FARDON, REMI · 2022 to 2023
$501k
NIAAA NIH HHS P50 AA006420NIAAA NIH HHS P60 AA006420NIAAA NIH HHS R01 AA026999NIAAA NIH HHS R01 AA028549NIAAA NIH HHS T32 AA007456NIDA NIH HHS R01 DA056602NIDA NIH HHS R21 DA053443NIDA NIH HHS U01 DA044451NIDA NIH HHS U01 DA051972
6 · The paper itself

Abstract

Over the past two decades, the escalating prescription of opioid medications for pain management has culminated in a widespread opioid epidemic, significantly impacting public health, social dynamics, and economic stability. The urgent need for improved treatments for opioid addiction necessitates a deeper understanding of its biological underpinnings, with genetic variations playing a crucial role in individual susceptibility to opioid use disorder (OUD) and influencing clinical practices. In this study, we leverage the genetic diversity of four rat strains (ACI/N, BN/NHsd, WKY/N, and F344/N) to examine the contribution of genetic factors to oxycodone metabolism and addiction-like behaviors. We used the extended access to intravenous oxycodone self-administration procedure (12 h/day, 0.15 mg/kg/injection) to comprehensively characterize oxycodone-related behaviors and pharmacokinetics. We measured escalation of oxycodone self-administration, motivation for drug consumption, tolerance to the analgesic effects of oxycodone, withdrawal-induced hyperalgesia, and oxycodone-induced respiratory depression. Additionally, we examined oxycodone-seeking behavior after four weeks of withdrawal by reintroducing the animals to environmental and cue stimuli previously associated with oxycodone self-administration. The findings revealed notable strain differences in several behavioral measures, including oxycodone metabolism. Intriguingly, BN/NHsd and WKY/N strains exhibited similar drug intake and escalation patterns but displayed significant disparities in oxycodone and oxymorphone metabolism. Minimal sex differences were observed within strains, primarily relating to oxycodone metabolism. In conclusion, this study identifies strain differences in the behavioral responses and pharmacokinetics associated with oxycodone self-administration in rats, providing a robust foundation for identifying genetic and molecular variants associated with various facets of the opioid addiction process.

Indexed as

Opioid-Related DisordersOxycodoneAnalgesics, OpioidAnimalsFemaleMaleRatsRats, Inbred ACIRats, Inbred F344Rats, Inbred WKYSelf AdministrationAnalgesics, OpioidOxycodoneOpioid use disorderOxycodoneRatSelf-administrationSexStrain

Identifiers

PMID37327971
PMCPMC10353778
OpenAlexW4380997559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.